EXCLUSIVE: Sunshine Biopharma Advances Its Lead Coronavirus Drug Candidate Into IND-Enabling Studies That Showed Broad-Spectrum SARS-CoV-2 Variant Activity In In-Vivo Study

Benzinga Newsdesk www.benzinga.com Positive 86.9%

Neg 0% Neu 0% Pos 86.9%

Comments

No comments yet. Be the first!